Oura Inc.: Omnichannel Wholesale Shift Surges to 40.41% of Revenue as 21.55% Free Cash Flow Margin Offsets $132.3 Million Warranty Reserve
Date : 2026-09-10
Reading : 233
HDIN Executive Takeaways
1. Oura Inc. [OURA] expanded revenue 74.1% year-over-year to $1.215 billion in 9M FY26, generating $261.8 million in free cash flow (21.55% margin) as 89.0% gross margin subscriptions offset hardware costs.
2. Assembly concentration across Mexico ($3.73M tooling) and Estonia ($4.62M tooling) faces operational exposure from an active U.S. International Trade Commission import exclusion complaint filed by Samsung Electronics Co., Ltd.
3. Accrued balance sheet warranty and return liabilities expanded 56.41% to $220.701 million in 9M FY26, establishing an operational overhang ahead of public listing.
Segmental Realities, Unit Economic Mechanics, and Margin Compression
Oura Inc. operates an integrated commercial model pairing upfront smart ring hardware sales with mandatory recurring software subscriptions. For the nine months ended June 30, 2026, total consolidated revenue reached $1,214,506 thousand, representing an expansion of 74.1% over the prior-year period.
Hardware revenue expanded 65.4% year-over-year during 9M FY26 to $973,980 thousand (80.20% of total revenue), while Membership recurring subscription revenue increased 121.0% to $240,526 thousand (19.80% of total revenue).
Table Revenue Mix and Quarterly Operating Performance — FY2024–Q3 FY2026
The business displays quarterly seasonality, with peak hardware shipments occurring during the first fiscal quarter ending December 31.
Table Quarterly Revenue Trend and Operating Metrics
Consolidated gross margin contracted from 64.93% in FY24 to 51.88% in FY25, recovering to 54.52% in 9M FY26. For the nine months ended June 30, 2026, Membership gross margin registered at 89.00%, generating $214,068 thousand in gross profit on $26,458 thousand in cost of revenue. Hardware gross margin contracted to 46.01%, generating $448,099 thousand in gross profit on $525,881 thousand in cost of revenue. Consolidated cost of goods sold totaled $552,339 thousand. Product cost inflation of $14.8 million was recorded in FY25 due to the introduction of all-titanium covers and complex sensor assemblies on Oura Ring 4.
Organic customer acquisition accounted for approximately 40% of new members in 9M FY26 via word-of-mouth and customer referrals. Approximately 63% of new members chose the $69.99 upfront annual plan over the $5.99 monthly plan ($71.88 annual run-rate).
Cumulative paid members reached 5.0 million by June 30, 2026, yielding a forward run-rate annual recurring revenue (ARR) of $353.45 million and a monthly recurring revenue (MRR) of $29.45 million. Engagement metrics register a DAU-to-MAU ratio of approximately 65%, with members opening the application at least 3.5 times per day and exhibiting a median wear time of 23 hours per day. Female members have expanded at a compound annual rate of 143% since FY24, compared to 94% for male members, and now represent 72% of the active base. Existing members upgrading hardware accounted for 11% of unit volume in 9M FY26, up from 9% in FY25 and 5% in FY24.
Table Key Operating Milestones and User Growth Metrics (December 2024–June 2026)
*Quarterly metric; ^Full fiscal year metric; #Nine-month period metric.
Distribution channel disaggregation shows an increasing wholesale mix, which expanded from 27.07% in FY24 to 40.41% ($490,715 thousand) in 9M FY26 across approximately 8,400 global retail doors, including Best Buy, Costco, Target, Walmart, Amazon, Harrods, John Lewis, and JB Hi-Fi. Retail channels drove 49% ($477,250 thousand) of hardware sales in 9M FY26. B2B enterprise sales accounted for the residual $13,465 thousand in wholesale hardware revenue (1.38% of hardware revenue; 1.11% of total revenue).
Table Revenue Distribution by Sales Channel (FY2024–9M FY2026)
Wholesale agreements do not mandate minimum purchase commitments, leaving Oura Inc. exposed to retailer inventory destocking. Wholesale expansion lowered blended RPU from $332 in FY24 to $326 in FY25 and $311 in 9M FY26, driven by variable consideration concessions governed by ASC 606 (including volume discounts, promotional allowances, and price protections). Residual inventory markdowns for Oura Ring 3 upon the release of Oura Ring 4 were treated as direct hardware revenue reductions.
Table Operating Expense Structure and Profitability Trends (FY2024–9M FY2026)
In 9M FY26, Sales & Marketing increased $117.6 million to $257,858 thousand due to a $72.8 million rise in paid media and marketing for the Oura Ring 5 launch. Research & Development expenses doubled to $206,800 thousand on a $52.1 million expansion in engineering compensation. General & Administrative costs rose to $126,321 thousand, driven by $48.3 million in legal and professional fees associated with active patent defenses. Net income for 9M FY26 reached $60.8 million.
Operating cash flow for 9M FY26 reached $328,008 thousand (up 142.4% from $135,315 thousand in 9M FY25), supported by a $43.2 million cash benefit from inventory liquidations ($79.9 million working capital clearing effect) and $52.4 million in deferred subscription inflows, offset by a $78.9 million trade receivables expansion. Capital expenditures totaled $66,240 thousand (up from $21,724 thousand in FY25 and $13,189 thousand in FY24), yielding free cash flow of $261,768 thousand (21.55% margin). Cash and cash equivalents stood at $371.76 million as of June 30, 2026, against $380.14 million drawn on its senior secured revolving credit facility with JPMorgan Chase Bank, N.A., which carries a total borrowing capacity of $525.0 million maturing in June 2029.
Infrastructure Layout, Sourcing Constraints, and Regional Footprint
Oura Inc. maintains an outsourced manufacturing model, holding zero internal production facilities and subcontracting physical fabrication to contract manufacturers (CMs) located primarily in Mexico and Estonia.
The company retains ownership of proprietary assembly tooling, testing machinery, and calibration equipment installed at foreign CM sites.
Table Geographic Distribution of Tooling and Machinery Assets (September 30, 2025)
Single-source dependencies persist for custom lithium-ion micro-batteries and proprietary photoplethysmography (PPG) optical sensor packages procured from East Asia. Final assembly lines for rings and charging docks rely on single-source contracts per assembly geography. Standard titanium variants use medical-grade alloys, while premium models incorporate ceramic shells, exposing procurement costs to commodity pricing and import tariffs.
Corporate operations run via leased space at 500 Pine Street in San Francisco (47,352 square feet under an operating lease expiring August 2031), while its global headquarters at 415 Kearny Street was acquired on July 30, 2026, for $41.5 million in cash. International engineering centers operate out of Oulu and Helsinki, Finland, supported by leased offices in San Diego and Santa Monica, California, and shared facilities in Tampere, Finland, and London, United Kingdom. Primary distribution logistics are fully managed through third-party logistics (3PL) fulfillment centers in the United States and Western Europe.
Ship-to revenue remains heavily weighted toward North America, representing 80.42% ($976,677 thousand) of consolidated sales in 9M FY26, while international territories generated the remaining 19.58% ($237,829 thousand). No single foreign jurisdiction generated more than 10% of revenue in any reported period.
Table Revenue Distribution by Geographic Market (FY2024–9M FY2026)
Inventory management operates under lower of cost or net realizable value accounting using the weighted-average cost method. A $6.7 million excess and obsolescence charge was recorded in FY24 to impair legacy Oura Ring 3 units. Contract manufacturing agreements enforce rigid 12-month rolling forecasts, with frozen non-cancellable commitments covering one to three months.
Table Inventory Composition and Working Capital Trend Analysis (September 2024–June 2026)
Loss provisions on firm purchase commitments recorded directly to cost of goods sold totaled $10.0 million in FY24, $4.6 million in FY25, and $1.0 million in 9M FY26, leaving an accrued balance sheet liability of $5.2 million as of June 30, 2026. Future non-cancellable purchase obligations totaled $119.7 million, mostly maturing within 12 months. Returned rings are not resold via secondary refurbishment channels due to biocompatibility tolerances, battery limits, and jewelry positioning; units are scrapped for precious metal recovery or dismantled for component evaluation.
Table Supply Chain Structure, Vulnerabilities, and Risk Mitigation Measures
Commercial healthcare operations balance general wellness exemptions with partner clearances. Ring biometric tracking functions (resting heart rate at ~99% accuracy, HRV at ~98%, sleep staging at ~96%, and cycle tracking at ~96%, supported by an independent 2025 Air Force Research Laboratory PPG study) are structured under the FDA's January 2026 General Wellness Guidance.
The proprietary AI engine relies on three operational tiers:
1. Proprietary Health Foundation Models decoding physiological patterns from 42 billion hours of continuous biometric data.
2. Domain-Specific Health Models executing Sleep Stages, Stress Resilience, Nighttime BP, and Cardiovascular Age algorithms.
3. Custom Large Language Models (Oura Women's Health Expert and Oura Advisor fine-tuned with webAI) delivering natural-language insights.
The Fertile Window algorithm operates under FDA enforcement discretion in the United States and is registered as a self-certified Class I medical device software under the European Union Medical Devices Regulation (EU MDR). Direct CPT coding reimbursement paths (e.g., CPT 99453, 99454 for Remote Patient Monitoring) are absent, and products are not directly covered by commercial payors or government healthcare programs.
Hardware purchases qualify for pre-tax reimbursement under IRS consumer Flexible Spending Account (FSA) and Health Savings Account (HSA) regulations. External clinical integrations include Natural Cycles (FDA-cleared contraception), Dexcom's Stelo continuous glucose biosensor, Lumeris' Essence Healthcare Medicare Advantage plans, Cigna employer benefits, Maven Clinic electronic health record integrations, and Eli Lilly and Company's LillyDirect program for GLP-1 weight management sizing kits. More than 175 peer-reviewed publications have leveraged ring data across institutions including Harvard Medical School, Stanford University, Scripps Research, and the 63,000-participant UCSF TemPredict Study. Clinical research contracts do not generate standalone material revenue.
Balance Sheet Liabilities, Legal Exposures, and HDIN Institutional Verdict
Oura Inc.’s balance sheet exhibits significant accruals stemming from manufacturing defects in early Oura Ring 4 production cohorts, which experienced accelerated battery degradation.
Table Supply Chain Structure, Vulnerabilities, and Risk Mitigation Measures
This hardware defect required an incremental warranty charge of $84.4 million in FY25, driving full-year warranty provisions charged to COGS to $103,334 thousand. Provisions reached $113,170 thousand during 9M FY26.
Table Warranty Reserve Roll-Forward and Liability Development (FY2024–9M FY2026)
Cash warranty fulfillments escalated to $75,483 thousand in 9M FY26, while refund liabilities for sales returns expanded to $88,400 thousand. Corresponding right-to-recover assets classified within prepaid expenses and other current assets rose from $0 at September 30, 2024, to $15,504 thousand in FY25 and $26,799 thousand at June 30, 2026.
Table Key Risk Factors, Severity Assessment, and Mitigation Framework (Based on S-1 Disclosures)
Litigation liabilities present direct operational and financial risks:
* Samsung Electronics Co., Ltd. ITC Action: Filed December 12, 2025, alleging infringement of four patents spanning software algorithms and flexible printed circuit board (PCB) architectures. Samsung is petitioning for a U.S. import exclusion order, threatening distribution across Oura's primary market (80.42% of sales).
* Omni MedSci, Inc. Infringement Suit: Filed December 20, 2025, in the U.S. District Court for the Eastern District of Texas, alleging infringement of wearable optical sensor patents and seeking approximately $120 million in damages (32.3% of Oura's $371.8 million cash reserves).
* Competitor Benchmarking: Lower-cost market entrants (Ultrahuman, Circular, RingConn) are cited in competitive risk factors regarding pricing pressure and subscription-free alternatives, but are not named parties in active litigation sections.
* Equity Claims: Former CEO Harpreet Singh Rai filed actions in N.D. Cal (November 7, 2025) and D. Del (May 29, 2026) seeking rescission and restitution regarding a September 2024 equity repurchase. Dr. Peter Attia filed an advisory equity claim in N.D. Cal (trial set for August 31, 2026). Gurinder Bal and CTR Capital filed advisory equity claims in S.F. Superior Court (trial set for September 13, 2027).
Oura Inc. relies on zero material third-party patent licenses in cost of goods sold. Long-term software purchase commitments rose from $5.6 million in FY25 to $160.1 million as of June 30, 2026, following an April 2026 data-processing contract executed to service 5.0 million active subscribers. Under its $525.0 million revolving credit facility with JPMorgan Chase Bank, N.A., all material intellectual property assets are encumbered as first-priority collateral.
Table Porter’s Five Forces Analysis of the Smart Ring Industry
Capital restructuring ahead of the offering cleared early-stage venture investors. Between October 1, 2025, and June 30, 2026, the company deployed $1.173 billion in cash repurchases:
* Private Tender Offer (February 19, 2026): Retired 13,295,528 preferred shares at $40.18 per share ($534.2 million).
* Deferred Settlement Contracts (March–April 2026): Repurchased 1,173,591 common and 6,933,744 preferred shares at $53.57 to $56.25 per share ($437.0 million).
* Bilateral Buybacks (October 2025–March 2026): Repurchased 385,398 common and 2,257,412 preferred shares at $25.69 to $40.60 per share ($105.9 million).
* Forward Equity Settlement (January 9, 2026): Retired 5,438,236 preferred shares at an implied price of $17.71 per share via $96.4 million in restricted cash collateral.
* Related-Party Buyback: In February 2026, repurchased 1,617,721 Series B preferred shares from Forerunner Ventures (represented on the board by Eurie Kim) at $40.18 per share ($65.0 million).
* Officer Promissory Notes: Issued $3.5 million in notes to CFO Sean Brecker (interest at greater of 3.6% or SOFR + 3.5%), repaid in full and cancelled July 8, 2026.
* Prior Acquisitions: Acquired Human Engineering Health Oy in September 2024 for $8.6 million in equity (issuing 815,063 Series C-1 shares valued at $9.4 million), approved via an independent Special Transaction Committee.
Preferred financings from FMR LLC provided institutional capital: Series D ($125.0 million at $25.69 per share in December 2024) and Series E ($629.6 million in September 2025 and $10.0 million in February 2026 at $53.57 per share). Implied private equity valuation expanded from $3.065 billion at June 30, 2024, to $9.656 billion at June 27, 2026 ($56.25 per share).
Post-IPO governance operates under a unified single-class voting structure. Authorized stock consists of 4,500,000,000 common shares ($0.00001 par value; one vote per share) and 100,000,000 preferred shares ($0.00001 par value). The board of directors is divided into three staggered classes: Class I (Eurie Kim, Mikko Kuusi, David Sze, Jason Warnick; term ending at the first post-IPO annual meeting), Class II (Timo Ahopelto, Wen Hsieh, Leslie Kilgore; term ending at the second meeting), and Class III (Thomas Hale, David Shuman, Dennis Durkin; term ending at the third meeting). Removal of directors requires cause and a 66.67% voting majority; cumulative voting and stockholder action by written consent are prohibited. The 2026 Incentive Award Plan and ESPP contain annual evergreen increases of up to 5% and 1% of common shares outstanding, respectively.
Incentive bonuses achieved 120% of target payout based on annual corporate revenue and Adjusted EBITDA thresholds. Executive Chairman David Shuman oversees board governance alongside external nominees Leslie Kilgore and Mikko Kuusi. Stock-based compensation recognized in 9M FY26 was $10.01 million (0.82% of revenue), up from $5.93 million in 9M FY25. However, the satisfaction of double-trigger performance conditions upon IPO effectiveness will trigger a cumulative non-cash compensation charge of $169.1 million against opening post-offering GAAP results.
HDIN Research concludes that Oura Inc. has built an exceptional consumer health platform, supported by negative working capital dynamics in software, zero-day CAC recovery ($61.38 net upfront hardware contribution), and an 89.00% gross margin subscription profile.
However, public market underwriting must discount for two critical operational risks:
1. Sourcing Vulnerability & Warranty Tail: The $132.3 million balance sheet warranty reserve confirms that micro-lithium-ion battery failures can rapidly erode gross margin performance. While Oura Ring 5 features redesigned dual-sourced cells, any recurring degradation across aging cohorts will pressure near-term cash flow conversion.
2. Regulatory & Exclusion Exposure: With 80.42% of revenue generated in the United States and assembly concentrated across foreign CMs in Mexico and Estonia, Samsung Electronics Co., Ltd.’s pending ITC patent complaint threatens Oura's primary physical import pipeline. Simultaneously, the $120 million patent damages claim asserted by Omni MedSci threatens nearly one-third of the company's liquid cash reserves ($371.8 million).
While the underlying unit economics support premium trading multiples, public market valuations will remain bounded by the resolution of the Samsung ITC trade investigation and the normalization of Oura Ring 4 warranty claims.
Presentation Download & Video Access
Presentation Download: Click the PDF download link under 'Related Topics' to access the full institutional presentation of this report.
Video Link: Click this link to watch the HDIN analyst briefing on YouTube.
About HDIN Research
HDIN Research is a global market intelligence and strategic advisory firm specializing in institutional-grade financial analysis, supply chain audits, and macroeconomic forecasting. Our dedicated sector analysts deliver actionable, data-driven insights tailored for private equity, hedge funds, and corporate strategy teams. Visit us at http://www.hdinresearch.com.
2026 AI Transparency Footer
This intelligence report was authored by HDIN Research analysts following a rigorous audit of official corporate filings. AI was utilized for massive-scale data synthesis and structural drafting, ensuring 100% inclusion of reported data points. All strategic insights, financial modeling, and final verdicts were verified by our editorial board to ensure professional accuracy and compliance with 2026 Google Search E-E-A-T standards.
1. Oura Inc. [OURA] expanded revenue 74.1% year-over-year to $1.215 billion in 9M FY26, generating $261.8 million in free cash flow (21.55% margin) as 89.0% gross margin subscriptions offset hardware costs.
2. Assembly concentration across Mexico ($3.73M tooling) and Estonia ($4.62M tooling) faces operational exposure from an active U.S. International Trade Commission import exclusion complaint filed by Samsung Electronics Co., Ltd.
3. Accrued balance sheet warranty and return liabilities expanded 56.41% to $220.701 million in 9M FY26, establishing an operational overhang ahead of public listing.
Segmental Realities, Unit Economic Mechanics, and Margin Compression
Oura Inc. operates an integrated commercial model pairing upfront smart ring hardware sales with mandatory recurring software subscriptions. For the nine months ended June 30, 2026, total consolidated revenue reached $1,214,506 thousand, representing an expansion of 74.1% over the prior-year period.
Hardware revenue expanded 65.4% year-over-year during 9M FY26 to $973,980 thousand (80.20% of total revenue), while Membership recurring subscription revenue increased 121.0% to $240,526 thousand (19.80% of total revenue).
Table Revenue Mix and Quarterly Operating Performance — FY2024–Q3 FY2026
| Revenue Segment | FY2024 | % of Total | FY2025 | % of Total | 9M Ended Jun 30, 2025 | % of Total | 9M Ended Jun 30, 2026 | % of Total |
| Hardware Revenue | $331,203 | 81.43% | $749,393 | 82.55% | $588,726 | 84.40% | $973,980 | 80.20% |
| Membership Revenue | $75,548 | 18.57% | $158,463 | 17.45% | $108,843 | 15.60% | $240,526 | 19.80% |
| Total Revenue | $406,751 | 100.00% | $907,856 | 100.00% | $697,569 | 100.00% | $1,214,506 | 100.00% |
The business displays quarterly seasonality, with peak hardware shipments occurring during the first fiscal quarter ending December 31.
Table Quarterly Revenue Trend and Operating Metrics
| Segment / Metric (USD in Thousands) | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
| Hardware Revenue | $202,592 | $196,120 | $190,014 | $160,667 | $385,860 | $272,308 | $315,812 |
| Membership Revenue | $28,092 | $36,475 | $44,276 | $49,620 | $65,107 | $82,507 | $92,912 |
| Total Revenue | $230,684 | $232,595 | $234,290 | $210,287 | $450,967 | $354,815 | $408,724 |
| Rings Sold (M) | 0.6 | 0.6 | 0.6 | 0.5 | 1.4 | 0.8 | 1.0 |
| Paid Members (M) | 1.5 | 2.1 | 2.5 | 2.9 | 3.4 | 4.6 | 5.0 |
| Average Hardware RPU | $338 | $327 | $317 | $321 | $276 | $340 | $316 |
Consolidated gross margin contracted from 64.93% in FY24 to 51.88% in FY25, recovering to 54.52% in 9M FY26. For the nine months ended June 30, 2026, Membership gross margin registered at 89.00%, generating $214,068 thousand in gross profit on $26,458 thousand in cost of revenue. Hardware gross margin contracted to 46.01%, generating $448,099 thousand in gross profit on $525,881 thousand in cost of revenue. Consolidated cost of goods sold totaled $552,339 thousand. Product cost inflation of $14.8 million was recorded in FY25 due to the introduction of all-titanium covers and complex sensor assemblies on Oura Ring 4.
Organic customer acquisition accounted for approximately 40% of new members in 9M FY26 via word-of-mouth and customer referrals. Approximately 63% of new members chose the $69.99 upfront annual plan over the $5.99 monthly plan ($71.88 annual run-rate).
Cumulative paid members reached 5.0 million by June 30, 2026, yielding a forward run-rate annual recurring revenue (ARR) of $353.45 million and a monthly recurring revenue (MRR) of $29.45 million. Engagement metrics register a DAU-to-MAU ratio of approximately 65%, with members opening the application at least 3.5 times per day and exhibiting a median wear time of 23 hours per day. Female members have expanded at a compound annual rate of 143% since FY24, compared to 94% for male members, and now represent 72% of the active base. Existing members upgrading hardware accounted for 11% of unit volume in 9M FY26, up from 9% in FY25 and 5% in FY24.
Table Key Operating Milestones and User Growth Metrics (December 2024–June 2026)
| Operational Milestone Date | Dec 31, 2024 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
| Paid Members (Cumulative) | 1.5 Million | 2.5 Million | 2.9 Million | 3.4 Million | 4.6 Million | 5.0 Million |
| Rings Sold (Period Volume) | 0.6 Million* | 0.6 Million* | 2.3 Million^ | 1.4 Million* | 0.8 Million* | 3.1 Million# |
| Hardware Average RPU | $332 | — | $326 | — | — | $311 |
| 12-Month Member Retention | ~85% | 87% | — | — | — | 85% |
Distribution channel disaggregation shows an increasing wholesale mix, which expanded from 27.07% in FY24 to 40.41% ($490,715 thousand) in 9M FY26 across approximately 8,400 global retail doors, including Best Buy, Costco, Target, Walmart, Amazon, Harrods, John Lewis, and JB Hi-Fi. Retail channels drove 49% ($477,250 thousand) of hardware sales in 9M FY26. B2B enterprise sales accounted for the residual $13,465 thousand in wholesale hardware revenue (1.38% of hardware revenue; 1.11% of total revenue).
Table Revenue Distribution by Sales Channel (FY2024–9M FY2026)
| Distribution Channel (USD in Thousands) | FY2024 | % of Total | FY2025 | % of Total | 9M Ended Jun 30, 2025 | % of Total | 9M Ended Jun 30, 2026 | % of Total |
| Direct-to-Consumer (DTC) | $296,646 | 72.93% | $554,540 | 61.08% | $420,457 | 60.27% | $723,791 | 59.59% |
| Wholesale (Retail & Enterprise) | $110,105 | 27.07% | $353,316 | 38.92% | $277,112 | 39.73% | $490,715 | 40.41% |
| Total Revenue | $406,751 | 100.00% | $907,856 | 100.00% | $697,569 | 100.00% | $1,214,506 | 100.00% |
Wholesale agreements do not mandate minimum purchase commitments, leaving Oura Inc. exposed to retailer inventory destocking. Wholesale expansion lowered blended RPU from $332 in FY24 to $326 in FY25 and $311 in 9M FY26, driven by variable consideration concessions governed by ASC 606 (including volume discounts, promotional allowances, and price protections). Residual inventory markdowns for Oura Ring 3 upon the release of Oura Ring 4 were treated as direct hardware revenue reductions.
Table Operating Expense Structure and Profitability Trends (FY2024–9M FY2026)
| Operating Expense Breakdown (USD in Thousands) | FY2024 | % of Rev | FY2025 | % of Rev | 9M FY2025 | % of Rev | 9M FY2026 | % of Rev |
| Sales & Marketing | $108,410 | 26.65% | $202,217 | 22.27% | $140,273 | 20.11% | $257,858 | 21.23% |
| Research & Development | $90,596 | 22.27% | $141,957 | 15.64% | $101,078 | 14.49% | $206,800 | 17.03% |
| General & Administrative | $51,648 | 12.70% | $81,506 | 8.98% | $54,409 | 7.80% | $126,321 | 10.40% |
| Total Operating Expenses | $250,654 | 61.62% | $425,680 | 46.89% | $295,760 | 42.40% | $590,979 | 48.66% |
| Operating Income | $13,440 | 3.30% | $45,332 | 4.99% | $60,265 | 8.64% | $71,188 | 5.86% |
In 9M FY26, Sales & Marketing increased $117.6 million to $257,858 thousand due to a $72.8 million rise in paid media and marketing for the Oura Ring 5 launch. Research & Development expenses doubled to $206,800 thousand on a $52.1 million expansion in engineering compensation. General & Administrative costs rose to $126,321 thousand, driven by $48.3 million in legal and professional fees associated with active patent defenses. Net income for 9M FY26 reached $60.8 million.
Operating cash flow for 9M FY26 reached $328,008 thousand (up 142.4% from $135,315 thousand in 9M FY25), supported by a $43.2 million cash benefit from inventory liquidations ($79.9 million working capital clearing effect) and $52.4 million in deferred subscription inflows, offset by a $78.9 million trade receivables expansion. Capital expenditures totaled $66,240 thousand (up from $21,724 thousand in FY25 and $13,189 thousand in FY24), yielding free cash flow of $261,768 thousand (21.55% margin). Cash and cash equivalents stood at $371.76 million as of June 30, 2026, against $380.14 million drawn on its senior secured revolving credit facility with JPMorgan Chase Bank, N.A., which carries a total borrowing capacity of $525.0 million maturing in June 2029.
Infrastructure Layout, Sourcing Constraints, and Regional Footprint
Oura Inc. maintains an outsourced manufacturing model, holding zero internal production facilities and subcontracting physical fabrication to contract manufacturers (CMs) located primarily in Mexico and Estonia.
The company retains ownership of proprietary assembly tooling, testing machinery, and calibration equipment installed at foreign CM sites.
Table Geographic Distribution of Tooling and Machinery Assets (September 30, 2025)
| Geographic Region | Tooling & Machinery Assets (Sept 30, 2025) | Share of Physical Equipment | Operational and Logistics Relevance |
| United States | $5,963,000 | 24.70% | Quality testing lines, prototyping, firmware integration. |
| Finland | $5,455,000 | 22.60% | Historical engineering center; optical calibration tooling. |
| Estonia | $4,615,000 | 19.12% | Precision northern European contract manufacturing. |
| Mexico | $3,730,000 | 15.45% | Nearshore final assembly supporting North American demand. |
| Rest of World | $4,378,000 | 18.13% | Semiconductor packaging and flexible PCB calibration (Asia). |
| Total Long-Lived Assets | $24,141,000 | 100.00% | Consolidated physical machinery baseline. |
Single-source dependencies persist for custom lithium-ion micro-batteries and proprietary photoplethysmography (PPG) optical sensor packages procured from East Asia. Final assembly lines for rings and charging docks rely on single-source contracts per assembly geography. Standard titanium variants use medical-grade alloys, while premium models incorporate ceramic shells, exposing procurement costs to commodity pricing and import tariffs.
Corporate operations run via leased space at 500 Pine Street in San Francisco (47,352 square feet under an operating lease expiring August 2031), while its global headquarters at 415 Kearny Street was acquired on July 30, 2026, for $41.5 million in cash. International engineering centers operate out of Oulu and Helsinki, Finland, supported by leased offices in San Diego and Santa Monica, California, and shared facilities in Tampere, Finland, and London, United Kingdom. Primary distribution logistics are fully managed through third-party logistics (3PL) fulfillment centers in the United States and Western Europe.
Ship-to revenue remains heavily weighted toward North America, representing 80.42% ($976,677 thousand) of consolidated sales in 9M FY26, while international territories generated the remaining 19.58% ($237,829 thousand). No single foreign jurisdiction generated more than 10% of revenue in any reported period.
Table Revenue Distribution by Geographic Market (FY2024–9M FY2026)
| Geographic Segment (UN Region) | FY2024 | % of Total | FY2025 | % of Total | 9M FY2025 | % of Total | 9M FY2026 | % of Total |
| Northern America (United States) | $324,030 | 79.66% | $729,624 | 80.37% | $559,933 | 80.27% | $976,677 | 80.42% |
| Rest of the World | $82,721 | 20.34% | $178,232 | 19.63% | $137,636 | 19.73% | $237,829 | 19.58% |
| Consolidated Revenue | $406,751 | 100.00% | $907,856 | 100.00% | $697,569 | 100.00% | $1,214,506 | 100.00% |
Inventory management operates under lower of cost or net realizable value accounting using the weighted-average cost method. A $6.7 million excess and obsolescence charge was recorded in FY24 to impair legacy Oura Ring 3 units. Contract manufacturing agreements enforce rigid 12-month rolling forecasts, with frozen non-cancellable commitments covering one to three months.
Table Inventory Composition and Working Capital Trend Analysis (September 2024–June 2026)
| Inventory Category (USD in Thousands) | Sept 30, 2024 | Sept 30, 2025 | June 30, 2026 | 9-Month Change |
| Raw Materials | $5,630 | $25,859 | $21,670 | -16.20% |
| Finished Goods | $76,309 | $128,931 | $87,272 | -32.31% |
| Total Net Inventory | $81,939 | $154,790 | $108,942 | -29.62% |
Loss provisions on firm purchase commitments recorded directly to cost of goods sold totaled $10.0 million in FY24, $4.6 million in FY25, and $1.0 million in 9M FY26, leaving an accrued balance sheet liability of $5.2 million as of June 30, 2026. Future non-cancellable purchase obligations totaled $119.7 million, mostly maturing within 12 months. Returned rings are not resold via secondary refurbishment channels due to biocompatibility tolerances, battery limits, and jewelry positioning; units are scrapped for precious metal recovery or dismantled for component evaluation.
Table Supply Chain Structure, Vulnerabilities, and Risk Mitigation Measures
| Supply Chain Segment | Sourcing Strategy & Parameters | Structural Vulnerabilities | Risk Safeguards Disclosed in S-1 |
| Component Sourcing | Dual-sourcing for >70% of mechanical items; custom PPG and micro-batteries single-sourced in East Asia. | Semiconductor bottlenecks; exposure to raw copper and titanium tariffs. | Pre-funding buffer stocks; $21.7 million in raw material reserves held at June 30, 2026. |
| Assembly & Packaging | 100% outsourced to external CMs in Mexico and Estonia; tooling owned by Oura Inc. | No internal factory backup; exposure to trade actions and tariffs. | Geographic split across North America and Europe; rigorous third-party QMS line audits. |
| Logistics & Fulfillment | 3PL distribution networks in North America and Western Europe; API inventory tracking. | Peak seasonal carrier surcharges; potential customs inspection bottlenecks. | Early inventory stocking in U.S. 3PL warehouses prior to fourth-quarter holiday periods. |
Commercial healthcare operations balance general wellness exemptions with partner clearances. Ring biometric tracking functions (resting heart rate at ~99% accuracy, HRV at ~98%, sleep staging at ~96%, and cycle tracking at ~96%, supported by an independent 2025 Air Force Research Laboratory PPG study) are structured under the FDA's January 2026 General Wellness Guidance.
The proprietary AI engine relies on three operational tiers:
1. Proprietary Health Foundation Models decoding physiological patterns from 42 billion hours of continuous biometric data.
2. Domain-Specific Health Models executing Sleep Stages, Stress Resilience, Nighttime BP, and Cardiovascular Age algorithms.
3. Custom Large Language Models (Oura Women's Health Expert and Oura Advisor fine-tuned with webAI) delivering natural-language insights.
The Fertile Window algorithm operates under FDA enforcement discretion in the United States and is registered as a self-certified Class I medical device software under the European Union Medical Devices Regulation (EU MDR). Direct CPT coding reimbursement paths (e.g., CPT 99453, 99454 for Remote Patient Monitoring) are absent, and products are not directly covered by commercial payors or government healthcare programs.
Hardware purchases qualify for pre-tax reimbursement under IRS consumer Flexible Spending Account (FSA) and Health Savings Account (HSA) regulations. External clinical integrations include Natural Cycles (FDA-cleared contraception), Dexcom's Stelo continuous glucose biosensor, Lumeris' Essence Healthcare Medicare Advantage plans, Cigna employer benefits, Maven Clinic electronic health record integrations, and Eli Lilly and Company's LillyDirect program for GLP-1 weight management sizing kits. More than 175 peer-reviewed publications have leveraged ring data across institutions including Harvard Medical School, Stanford University, Scripps Research, and the 63,000-participant UCSF TemPredict Study. Clinical research contracts do not generate standalone material revenue.
Balance Sheet Liabilities, Legal Exposures, and HDIN Institutional Verdict
Oura Inc.’s balance sheet exhibits significant accruals stemming from manufacturing defects in early Oura Ring 4 production cohorts, which experienced accelerated battery degradation.
Table Supply Chain Structure, Vulnerabilities, and Risk Mitigation Measures
| Liability Account (USD in Thousands) | Sept 30, 2024 | Sept 30, 2025 | June 30, 2026 (Unaudited) | 9-Month Change (%) |
| Accrued Warranty Liability | $17,465 | $98,320 | $132,301 | +34.56% |
| Accrued Sales Returns (Refund Liability) | $12,994 | $42,780 | $88,400 | +106.64% |
| Total Balance Sheet Reserves | $30,459 | $141,100 | $220,701 | +56.41% |
This hardware defect required an incremental warranty charge of $84.4 million in FY25, driving full-year warranty provisions charged to COGS to $103,334 thousand. Provisions reached $113,170 thousand during 9M FY26.
Table Warranty Reserve Roll-Forward and Liability Development (FY2024–9M FY2026)
| Warranty Reserve Roll-Forward (USD in Thousands) | FY2024 | FY2025 | 9M Ended June 30, 2026 |
| Beginning Balance | $13,808 | $17,465 | $98,320 |
| Warranty Provisions (Charged to COGS) | $12,572 | $103,334 | $113,170 |
| Warranty Claims Settled (Fulfillments) | $(9,700) | $(28,760) | $(75,483) |
| Currency Translation Adjustments | $785 | $6,281 | $(3,706) |
| Ending Balance Sheet Accrual Balance | $17,465 | $98,320 | $132,301 |
Cash warranty fulfillments escalated to $75,483 thousand in 9M FY26, while refund liabilities for sales returns expanded to $88,400 thousand. Corresponding right-to-recover assets classified within prepaid expenses and other current assets rose from $0 at September 30, 2024, to $15,504 thousand in FY25 and $26,799 thousand at June 30, 2026.
Table Key Risk Factors, Severity Assessment, and Mitigation Framework (Based on S-1 Disclosures)
| Disclosed Risk Factor | Severity | Probability | Key Filing Evidence & Benchmarks | Mitigating Safeguards Grounded in S-1 |
| General Wellness Exemption Reversal | Critical | Possible | FDA Jan 2026 guidance non-binding; EU MDR lacks broad wellness discretion. | Structuring core metrics as exempt lifestyle indicators; utilizing partner clearances. |
| Health Advertising Class Actions | High | Likely | FTC Section 5(a) scrutiny; August 2026 sleep-accuracy consumer class action. | In-house clinical division (50+ PhDs, 5 MDs); validation trials with academic centers. |
| Biometric Privacy Enforcement | High | Likely | Exposure to Illinois BIPA, Washington MHMD; EU GDPR fines up to €35M / 7% turnover. | Non-sale health data guarantee; infrastructure engineering aligned with HIPAA and GDPR. |
| Government & Defense Data Rules | Medium | Possible | DOJ Data Security Program (July 2025); DoD NIST SP 800-171 and CMMC compliance. | Isolated hosting architecture for defense cohorts; scheduled CMMC audit completions. |
| Operating System Platform Restrictions | High | Likely | Apple ATT tracking friction; iOS/Android background Bluetooth pairing limits. | Device edge computing reducing sync frequency; expanding organic referral channels (40%). |
| Negative-Option Billing Scrutiny | Medium | Possible | California ARL, federal ROSCA scrutiny of dark patterns in subscription churn. | 63% upfront annual plan adoption ($69.99); simplified cancel-at-any-time controls. |
| Battery Failure & Warranty Reserves | Critical | Almost Certain | $84.4M Ring 4 incremental charge in FY25; $132.3M warranty reserve at June 30, 2026. | Dual-sourcing micro-cells; redesigned internal layout and battery cells on Ring 5. |
| Manufacturing Concentration Risk | High | Possible | Zero internal factories; single-source assembly in Mexico/Estonia; Asian micro-cells. | Rigid 1-3 month commitments; $21.7M strategic raw material inventory reserves. |
Litigation liabilities present direct operational and financial risks:
* Samsung Electronics Co., Ltd. ITC Action: Filed December 12, 2025, alleging infringement of four patents spanning software algorithms and flexible printed circuit board (PCB) architectures. Samsung is petitioning for a U.S. import exclusion order, threatening distribution across Oura's primary market (80.42% of sales).
* Omni MedSci, Inc. Infringement Suit: Filed December 20, 2025, in the U.S. District Court for the Eastern District of Texas, alleging infringement of wearable optical sensor patents and seeking approximately $120 million in damages (32.3% of Oura's $371.8 million cash reserves).
* Competitor Benchmarking: Lower-cost market entrants (Ultrahuman, Circular, RingConn) are cited in competitive risk factors regarding pricing pressure and subscription-free alternatives, but are not named parties in active litigation sections.
* Equity Claims: Former CEO Harpreet Singh Rai filed actions in N.D. Cal (November 7, 2025) and D. Del (May 29, 2026) seeking rescission and restitution regarding a September 2024 equity repurchase. Dr. Peter Attia filed an advisory equity claim in N.D. Cal (trial set for August 31, 2026). Gurinder Bal and CTR Capital filed advisory equity claims in S.F. Superior Court (trial set for September 13, 2027).
Oura Inc. relies on zero material third-party patent licenses in cost of goods sold. Long-term software purchase commitments rose from $5.6 million in FY25 to $160.1 million as of June 30, 2026, following an April 2026 data-processing contract executed to service 5.0 million active subscribers. Under its $525.0 million revolving credit facility with JPMorgan Chase Bank, N.A., all material intellectual property assets are encumbered as first-priority collateral.
Table Porter’s Five Forces Analysis of the Smart Ring Industry
| Porter's Force | Threat Level | Strategic Rationale and Filing Evidence |
| Threat of New Entrants | Moderate to High | High capital intensity offset by Samsung Galaxy Ring entry; defended by Oura's validated 2034 utility patent wall. |
| Bargaining Power of Suppliers | Moderate | High component exposure; single-source custom micro-batteries and PPG sensors drive warranty liabilities. |
| Bargaining Power of Buyers | Low to Moderate | Low buyer leverage; 85% 12-month retention, 65% DAU/MAU engagement, and longitudinal data history create lock-in. |
| Threat of Substitutes | Moderate | Smartwatches (Apple Watch) provide wrist alternative; rings retain passive overnight wear adherence (~23 hours/day). |
| Competitive Rivalry | High | Intense category friction; Samsung seeking U.S. import ban via active ITC patent complaint. |
Capital restructuring ahead of the offering cleared early-stage venture investors. Between October 1, 2025, and June 30, 2026, the company deployed $1.173 billion in cash repurchases:
* Private Tender Offer (February 19, 2026): Retired 13,295,528 preferred shares at $40.18 per share ($534.2 million).
* Deferred Settlement Contracts (March–April 2026): Repurchased 1,173,591 common and 6,933,744 preferred shares at $53.57 to $56.25 per share ($437.0 million).
* Bilateral Buybacks (October 2025–March 2026): Repurchased 385,398 common and 2,257,412 preferred shares at $25.69 to $40.60 per share ($105.9 million).
* Forward Equity Settlement (January 9, 2026): Retired 5,438,236 preferred shares at an implied price of $17.71 per share via $96.4 million in restricted cash collateral.
* Related-Party Buyback: In February 2026, repurchased 1,617,721 Series B preferred shares from Forerunner Ventures (represented on the board by Eurie Kim) at $40.18 per share ($65.0 million).
* Officer Promissory Notes: Issued $3.5 million in notes to CFO Sean Brecker (interest at greater of 3.6% or SOFR + 3.5%), repaid in full and cancelled July 8, 2026.
* Prior Acquisitions: Acquired Human Engineering Health Oy in September 2024 for $8.6 million in equity (issuing 815,063 Series C-1 shares valued at $9.4 million), approved via an independent Special Transaction Committee.
Preferred financings from FMR LLC provided institutional capital: Series D ($125.0 million at $25.69 per share in December 2024) and Series E ($629.6 million in September 2025 and $10.0 million in February 2026 at $53.57 per share). Implied private equity valuation expanded from $3.065 billion at June 30, 2024, to $9.656 billion at June 27, 2026 ($56.25 per share).
Post-IPO governance operates under a unified single-class voting structure. Authorized stock consists of 4,500,000,000 common shares ($0.00001 par value; one vote per share) and 100,000,000 preferred shares ($0.00001 par value). The board of directors is divided into three staggered classes: Class I (Eurie Kim, Mikko Kuusi, David Sze, Jason Warnick; term ending at the first post-IPO annual meeting), Class II (Timo Ahopelto, Wen Hsieh, Leslie Kilgore; term ending at the second meeting), and Class III (Thomas Hale, David Shuman, Dennis Durkin; term ending at the third meeting). Removal of directors requires cause and a 66.67% voting majority; cumulative voting and stockholder action by written consent are prohibited. The 2026 Incentive Award Plan and ESPP contain annual evergreen increases of up to 5% and 1% of common shares outstanding, respectively.
Incentive bonuses achieved 120% of target payout based on annual corporate revenue and Adjusted EBITDA thresholds. Executive Chairman David Shuman oversees board governance alongside external nominees Leslie Kilgore and Mikko Kuusi. Stock-based compensation recognized in 9M FY26 was $10.01 million (0.82% of revenue), up from $5.93 million in 9M FY25. However, the satisfaction of double-trigger performance conditions upon IPO effectiveness will trigger a cumulative non-cash compensation charge of $169.1 million against opening post-offering GAAP results.
HDIN Research concludes that Oura Inc. has built an exceptional consumer health platform, supported by negative working capital dynamics in software, zero-day CAC recovery ($61.38 net upfront hardware contribution), and an 89.00% gross margin subscription profile.
However, public market underwriting must discount for two critical operational risks:
1. Sourcing Vulnerability & Warranty Tail: The $132.3 million balance sheet warranty reserve confirms that micro-lithium-ion battery failures can rapidly erode gross margin performance. While Oura Ring 5 features redesigned dual-sourced cells, any recurring degradation across aging cohorts will pressure near-term cash flow conversion.
2. Regulatory & Exclusion Exposure: With 80.42% of revenue generated in the United States and assembly concentrated across foreign CMs in Mexico and Estonia, Samsung Electronics Co., Ltd.’s pending ITC patent complaint threatens Oura's primary physical import pipeline. Simultaneously, the $120 million patent damages claim asserted by Omni MedSci threatens nearly one-third of the company's liquid cash reserves ($371.8 million).
While the underlying unit economics support premium trading multiples, public market valuations will remain bounded by the resolution of the Samsung ITC trade investigation and the normalization of Oura Ring 4 warranty claims.
Presentation Download & Video Access
Presentation Download: Click the PDF download link under 'Related Topics' to access the full institutional presentation of this report.
Video Link: Click this link to watch the HDIN analyst briefing on YouTube.
About HDIN Research
HDIN Research is a global market intelligence and strategic advisory firm specializing in institutional-grade financial analysis, supply chain audits, and macroeconomic forecasting. Our dedicated sector analysts deliver actionable, data-driven insights tailored for private equity, hedge funds, and corporate strategy teams. Visit us at http://www.hdinresearch.com.
2026 AI Transparency Footer
This intelligence report was authored by HDIN Research analysts following a rigorous audit of official corporate filings. AI was utilized for massive-scale data synthesis and structural drafting, ensuring 100% inclusion of reported data points. All strategic insights, financial modeling, and final verdicts were verified by our editorial board to ensure professional accuracy and compliance with 2026 Google Search E-E-A-T standards.